Nektar Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Baxter International USD 1.76B 344M 2024-12
Biogen USD 2.6B 223.3M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Cipla INR 8B 1.22B 2025-03
Dr.Reddys Laboratories INR 14.65B 1.62B 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 183.75M 33.62M 2025-04
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Takeda JPY 385.11B 109.01B 2025-03
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
Xencor USD 39.67M 1.2M 2025-03



Nektar Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.